|
 |
|
|||||||
|
|||||||||
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
NM Siafakas, P Vermeire, NB Pride, P Paoletti, J Gibson, P Howard, JC Yernault, M Decramer, T Higenbottam, DS Postma, and al. et
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Religious Studies..Death
- Medicine..Mortality and Morbidity
- Oncology..Asthma
- Medicine..Tobacco and Smoking
- Sociology..Mortality
This article has been cited by other articles:
|
|
 |
|
  B. D. Broekhuizen, A. P. Sachs, R. Oostvogels, A. W Hoes, T. J. Verheij, and K. G. Moons The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review Fam. Pract., May 7, 2009; (2009) cmp026v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Quaak, C. P. van Schayck, A. M. Knaapen, and F. J. van Schooten Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur. Respir. J., March 1, 2009; 33(3): 468 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M P Swanney, G Ruppel, P L Enright, O F Pedersen, R O Crapo, M R Miller, R L Jensen, E Falaschetti, J P Schouten, J L Hankinson, et al. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction Thorax, December 1, 2008; 63(12): 1046 - 1051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Clini and N. Ambrosino Nonpharmacological treatment and relief of symptoms in COPD Eur. Respir. J., July 1, 2008; 32(1): 218 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Brophy, J. Kastelik, E. Gardiner, and M. Greenstone Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD Chronic Respiratory Disease, February 1, 2008; 5(1): 13 - 18. [Abstract] [PDF]
|
|
|
|
 |
|
 W. C. Tan and T. P. Ng COPD in Asia: Where East Meets West Chest, February 1, 2008; 133(2): 517 - 527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C.-W. Lau, M. S.-M. Ip, C. K.-W. Lai, K.-L. Choo, K.-S. Tang, L. Y.-C. Yam, and M. Chan-Yeung Variability of the Prevalence of Undiagnosed Airflow Obstruction in Smokers Using Different Diagnostic Criteria Chest, January 1, 2008; 133(1): 42 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Lee, T. Haselkorn, L. Borish, L. Rasouliyan, B. E. Chipps, and S. E. Wenzel Risk Factors Associated With Persistent Airflow Limitation in Severe or Difficult-to-Treat Asthma: Insights From the TENOR Study Chest, December 1, 2007; 132(6): 1882 - 1889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. P. de Jong, S. M. Uil, H. P. Grotjohan, D. S. Postma, H. A.M. Kerstjens, and J. W.K. van den Berg Oral or IV Prednisolone in the Treatment of COPD Exacerbations: A Randomized, Controlled, Double-blind Study Chest, December 1, 2007; 132(6): 1741 - 1747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C Grootendorst, S. A Gauw, R. M Verhoosel, P. J Sterk, J. J Hospers, D. Bredenbroker, T. D Bethke, P. S Hiemstra, and K. F Rabe Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD Thorax, December 1, 2007; 62(12): 1081 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Decramer, E. Berglund, U. Costabel, P. J. Sterk, and K. F. Rabe In memoriam Professor Paul Vermeire, 1936 2007: a tribute from the ERJ Chief Editors Eur. Respir. J., November 1, 2007; 30(5): 819 - 820. [Full Text] [PDF]
|
|
|
|
|
|
G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi Definition, epidemiology and natural history of COPD Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Khan, S. Kianpour, M. R. Stampfli, and L. J. Janssen Kinetics of in vitro bronchoconstriction in an elastolytic mouse model of emphysema Eur. Respir. J., October 1, 2007; 30(4): 691 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Rabe, S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 532 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S J Quantrill, R White, A Crawford, J S Barry, S Batra, P Whyte, and C M Roberts Short burst oxygen therapy after activities of daily living in the home in chronic obstructive pulmonary disease Thorax, August 1, 2007; 62(8): 702 - 705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tonnesen, L. Carrozzi, K. O. Fagerstrom, C. Gratziou, C. Jimenez-Ruiz, S. Nardini, G. Viegi, C. Lazzaro, I. A. Campell, E. Dagli, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy Eur. Respir. J., February 1, 2007; 29(2): 390 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bourbeau, J.-P. Collet, K. Schwartzman, T. Ducruet, D. Nault, C. Bradley, and the COPD axis of the Respiratory Health Network of Economic Benefits of Self-Management Education in COPD Chest, December 1, 2006; 130(6): 1704 - 1711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Boschetto, S Quintavalle, E Zeni, S Leprotti, A Potena, L Ballerin, A Papi, G Palladini, M Luisetti, L Annovazzi, et al. Association between markers of emphysema and more severe chronic obstructive pulmonary disease Thorax, December 1, 2006; 61(12): 1037 - 1042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Aggarwal, D. Gupta, and S. K. Jindal The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor. Chest, November 1, 2006; 130(5): 1454 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Esteban, J.M. Quintana, M. Aburto, J. Moraza, and A. Capelastegui A simple score for assessing stable chronic obstructive pulmonary disease QJM, November 1, 2006; 99(11): 751 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Bednarek, D Gorecka, J Wielgomas, M Czajkowska-Malinowska, J Regula, G Mieszko-Filipczyk, M Jasionowicz, R Bijata-Bronisz, M Lempicka-Jastrzebska, M Czajkowski, et al. Smokers with airway obstruction are more likely to quit smoking Thorax, October 1, 2006; 61(10): 869 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Halbert, J. L. Natoli, A. Gano, E. Badamgarav, A. S. Buist, and D. M. Mannino Global burden of COPD: systematic review and meta-analysis Eur. Respir. J., September 1, 2006; 28(3): 523 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Guo, M. H. Pittler, and E. Ernst Herbal medicines for the treatment of COPD: a systematic review. Eur. Respir. J., August 1, 2006; 28(2): 330 - 338. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Roberts, M. O. Farber, K. S. Knox, G. S. Phillips, N. Y. Bhatt, J. G. Mastronarde, and K. L. Wood FEV1/FVC Ratio of 70% Misclassifies Patients With Obstruction at the Extremes of Age. Chest, July 1, 2006; 130(1): 200 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Reilly Using computed tomographic scanning to advance understanding of chronic obstructive pulmonary disease. Proceedings of the ATS, July 1, 2006; 3(5): 450 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Rodriguez-Roisin COPD exacerbations {middle dot} 5: Management. Thorax, June 1, 2006; 61(6): 535 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Licker, I. Widikker, J. Robert, J.-G. Frey, A. Spiliopoulos, C. Ellenberger, A. Schweizer, and J.-M. Tschopp Operative mortality and respiratory complications after lung resection for cancer: impact of chronic obstructive pulmonary disease and time trends. Ann. Thorac. Surg., May 1, 2006; 81(5): 1830 - 1837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tsoumakidou, E. Papadopouli, N. Tzanakis, and N. M. Siafakas Airway Inflammation and Cellular Stress in Noneosinophilic Atopic Asthma Chest, May 1, 2006; 129(5): 1194 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. Jones and A. G. N. Agusti Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur. Respir. J., April 1, 2006; 27(4): 822 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zielinski, M. Bednarek, D. Gorecka, G. Viegi, S. S. Hurd, Y. Fukuchi, C. K. W. Lai, P. X. Ran, F. W. S. Ko, S. M. Liu, et al. Increasing COPD awareness. Eur. Respir. J., April 1, 2006; 27(4): 833 - 852. [Full Text] [PDF]
|
|
|
|
|
|
B. W. A. van der Strate, D. S. Postma, C.-A. Brandsma, B. N. Melgert, M. A. Luinge, M. Geerlings, M. N. Hylkema, A. van den Berg, W. Timens, and H. A. M. Kerstjens Cigarette Smoke-induced Emphysema: A Role for the B Cell? Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 751 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Orozco-Levi, J. Garcia-Aymerich, J. Villar, A. Ramirez-Sarmiento, J. M. Anto, and J. Gea Wood smoke exposure and risk of chronic obstructive pulmonary disease. Eur. Respir. J., March 1, 2006; 27(3): 542 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Casella, M. Miniati, S. Monti, F. Minichilli, F. Bianchi, and S. Simi No evidence of chromosome damage in chronic obstructive pulmonary disease (COPD) Mutagenesis, March 1, 2006; 21(2): 167 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A New Oxygen: kill or cure? Prehospital hyperoxia in the COPD patient Emerg. Med. J., February 1, 2006; 23(2): 144 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R A Stockley, N Chopra, L Rice, and on behalf of the SMS40026 Investigator Group Addition of salmeterol to existing treatment in patients with COPD: a 12 month study Thorax, February 1, 2006; 61(2): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Chapman, D. M. Mannino, J. B. Soriano, P. A. Vermeire, A. S. Buist, M. J. Thun, C. Connell, A. Jemal, T. A. Lee, M. Miravitlles, et al. Epidemiology and costs of chronic obstructive pulmonary disease Eur. Respir. J., January 1, 2006; 27(1): 188 - 207. [Full Text] [PDF]
|
|
|
|
|
|
J. Zaporozhan, S. Ley, R. Eberhardt, O. Weinheimer, S. Iliyushenko, F. Herth, and H.-U. Kauczor Paired Inspiratory/Expiratory Volumetric Thin-Slice CT Scan for Emphysema Analysis: Comparison of Different Quantitative Evaluations and Pulmonary Function Test Chest, November 1, 2005; 128(5): 3212 - 3220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Wagena, P. G. Knipschild, M. J. H. Huibers, E. F. M. Wouters, and C. P. van Schayck Efficacy of Bupropion and Nortriptyline for Smoking Cessation Among People at Risk for or With Chronic Obstructive Pulmonary Disease Arch Intern Med, October 24, 2005; 165(19): 2286 - 2292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cella, M. Saetta, S. Baraldo, G. Turato, A. Papi, G. Casoni, and M. Rigno Endothelial Cell Activity in Chronic Obstructive Pulmonary Disease Without Severe Pulmonary Hypertension Clinical and Applied Thrombosis/Hemostasis, October 1, 2005; 11(4): 435 - 440. [Abstract] [PDF]
|
|
|
|
|
|
D. Wilson, R. Adams, S. Appleton, R. Ruffin, and on behalf of the North West Adelaide (Cohort) Stud Difficulties Identifying and Targeting COPD and Population-Attributable Risk of Smoking for COPD: A Population Study Chest, October 1, 2005; 128(4): 2035 - 2042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cazzola, M. G. Matera, G. Donnarumma, M. A. Tufano, A. Sanduzzi, F. Marchetti, and F. Blasi Pharmacodynamics of Levofloxacin in Patients With Acute Exacerbation of Chronic Bronchitis Chest, October 1, 2005; 128(4): 2093 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Huiart, P. Ernst, and S. Suissa Cardiovascular Morbidity and Mortality in COPD Chest, October 1, 2005; 128(4): 2640 - 2646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Scala, M. Naldi, I. Archinucci, G. Coniglio, and S. Nava Noninvasive Positive Pressure Ventilation in Patients With Acute Exacerbations of COPD and Varying Levels of Consciousness Chest, September 1, 2005; 128(3): 1657 - 1666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Magdeleinat, A. Seguin, M. Alifano, S. Boubia, and J.-F. Regnard Early and long-term results of lung resection for non-small-cell lung cancer in patients with severe ventilatory impairment Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1099 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. D. Eisner, L. Trupin, P. P. Katz, E. H. Yelin, G. Earnest, J. Balmes, and P. D. Blanc Development and Validation of a Survey-Based COPD Severity Score Chest, June 1, 2005; 127(6): 1890 - 1897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tsoumakidou, N. Tzanakis, G. Chrysofakis, and N. M. Siafakas Nitrosative Stress, Heme Oxygenase-1 Expression and Airway Inflammation During Severe Exacerbations of COPD Chest, June 1, 2005; 127(6): 1911 - 1918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lindberg, A.-C. Jonsson, E. Ronmark, R. Lundgren, L.-G. Larsson, and B. Lundback Ten-Year Cumulative Incidence of COPD and Risk Factors for Incident Disease in a Symptomatic Cohort Chest, May 1, 2005; 127(5): 1544 - 1552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Vandevoorde, S. Verbanck, D. Schuermans, J. Kartounian, and W. Vincken FEV1/FEV6 and FEV6 as an Alternative for FEV1/FVC and FVC in the Spirometric Detection of Airway Obstruction and Restriction Chest, May 1, 2005; 127(5): 1560 - 1564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Buhl and S. G. Farmer Future Directions in the Pharmacologic Therapy of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 83 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. van der Woude, J. Zaagsma, D. S. Postma, T. H. Winter, M. van Hulst, and R. Aalbers Detrimental Effects of {beta}-Blockers in COPD: A Concern for Nonselective {beta}-Blockers Chest, March 1, 2005; 127(3): 818 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Viegi, G. Matteelli, A. Angino, A. Scognamiglio, S. Baldacci, J. B. Soriano, and L. Carrozzi The Proportional Venn Diagram of Obstructive Lung Disease in the Italian General Population Chest, October 1, 2004; 126(4): 1093 - 1101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.W.M. Willemse, N.H.T. ten Hacken, B. Rutgers, I.G.A.T. Lesman-Leegte, W. Timens, and D.S. Postma Smoking cessation improves both direct and indirect airway hyperresponsiveness in COPD Eur. Respir. J., September 1, 2004; 24(3): 391 - 396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Wagena, I. Kant, L. G. P. M. van Amelsvoort, E. F. M. Wouters, C. P. van Schayck, and G. M. H. Swaen Risk of Depression and Anxiety in Employees With Chronic Bronchitis: The Modifying Effect of Cigarette Smoking Psychosom Med, September 1, 2004; 66(5): 729 - 734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R Hurst and J A Wedzicha Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation Postgrad. Med. J., September 1, 2004; 80(947): 497 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The TORCH Study Group The TORCH (TOwards a Revolution in COPD Health) survival study protocol Eur. Respir. J., August 1, 2004; 24(2): 206 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. A. Calverley The GOLD Classification Has Advanced Understanding of COPD Am. J. Respir. Crit. Care Med., August 1, 2004; 170(3): 211 - 212. [Full Text] [PDF]
|
|
|
|
|
|
C M Roberts Short burst oxygen therapy for relief of breathlessness in COPD Thorax, August 1, 2004; 59(8): 638 - 640. [Full Text] [PDF]
|
|
|
|
|
|
C. Coronell, M. Orozco-Levi, R. Mendez, A. Ramirez-Sarmiento, J.B. Galdiz, and J. Gea Relevance of assessing quadriceps endurance in patients with COPD Eur. Respir. J., July 1, 2004; 24(1): 129 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cazzola and R. Dahl Inhaled Combination Therapy With Long-Acting {beta}2-Agonists and Corticosteroids in Stable COPD Chest, July 1, 2004; 126(1): 220 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Sutherland and R. M. Cherniack Management of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., June 24, 2004; 350(26): 2689 - 2697. [Full Text] [PDF]
|
|
|
|
|
|
P.M.A. Calverley and S.I. Rennard Application of management guidelines to the assessment of new medicines: driving us forward or holding us back? Eur. Respir. J., June 1, 2004; 23(6): 793 - 794. [Full Text] [PDF]
|
|
|
|
|
|
B.R. Celli, W. MacNee, A. Agusti, A. Anzueto, B. Berg, A.S. Buist, P.M.A. Calverley, N. Chavannes, T. Dillard, B. Fahy, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Eur. Respir. J., June 1, 2004; 23(6): 932 - 946. [Full Text] [PDF]
|
|
|
|
|
|
T. Iizasa, M. Suzuki, K. Yasufuku, A. Iyoda, M. Otsuji, S. Yoshida, Y. Sekine, K. Shibuya, Y. Saitoh, K. Hiroshima, et al. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma Ann. Thorac. Surg., June 1, 2004; 77(6): 1896 - 1902. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Wongsurakiat, K. N. Maranetra, C. Wasi, U. Kositanont, W. Dejsomritrutai, and S. Charoenratanakul Acute Respiratory Illness in Patients With COPD and the Effectiveness of Influenza Vaccination: A Randomized Controlled Study Chest, June 1, 2004; 125(6): 2011 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Buhling, C. Rocken, F. Brasch, R. Hartig, Y. Yasuda, P. Saftig, D. Bromme, and T. Welte Pivotal Role of Cathepsin K in Lung Fibrosis Am. J. Pathol., June 1, 2004; 164(6): 2203 - 2216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hasani, N. Toms, J. E. Agnew, M. Sarno, A. J. Harrison, and P. Dilworth The Effect of Inhaled Tiotropium Bromide on Lung Mucociliary Clearance in Patients With COPD Chest, May 1, 2004; 125(5): 1726 - 1734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-C. Ong, A.-C. Kor, W.-F. Chong, A. Earnest, and Y.-T. Wang Effects of Inhaled Furosemide on Exertional Dyspnea in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 1, 2004; 169(9): 1028 - 1033. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.P.K.J. Engelen, M. Orozco-Levi, N.E.P. Deutz, E. Barreiro, N. Hernandez, E.F.M. Wouters, J. Gea, and A.M.W.J. Schols Glutathione and glutamate levels in the diaphragm of patients with chronic obstructive pulmonary disease Eur. Respir. J., April 1, 2004; 23(4): 545 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B J Smith, S L Appleton, A J Veale, H J McElroy, D Veljkovic, and L Saccoia Eformoterol n-of-1 trials in chronic obstructive pulmonary disease poorly reversible to salbutamol Chronic Respiratory Disease, April 1, 2004; 1(2): 63 - 69. [Abstract] [PDF]
|
|
|
|
|
|
R. Buhl and S. G. Farmer Current and Future Pharmacologic Therapy of Exacerbations in Chronic Obstructive Pulmonary Disease and Asthma Proceedings of the ATS, April 1, 2004; 1(2): 136 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Buffels, J. Degryse, J. Heyrman, and M. Decramer Office Spirometry Significantly Improves Early Detection of COPD in General Practice: The DIDASCO Study Chest, April 1, 2004; 125(4): 1394 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Lee and K. B. Weiss Fracture Risk Associated with Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 855 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. R. Celli, C. G. Cote, J. M. Marin, C. Casanova, M. Montes de Oca, R. A. Mendez, V. Pinto Plata, and H. J. Cabral The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., March 4, 2004; 350(10): 1005 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Corrado, R. Ginanni, G. Villella, M. Gorini, A. Augustynen, D. Tozzi, A. Peris, S. Grifoni, A. Messori, C. Nozzoli, et al. Iron lung versus conventional mechanical ventilation in acute exacerbation of COPD Eur. Respir. J., March 1, 2004; 23(3): 419 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.W.M. Willemse, D.S. Postma, W. Timens, and N.H.T. ten Hacken The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation Eur. Respir. J., March 1, 2004; 23(3): 464 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tzanakis, U. Anagnostopoulou, V. Filaditaki, P. Christaki, and N. Siafakas Prevalence of COPD in Greece Chest, March 1, 2004; 125(3): 892 - 900. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wilson, L. Allegra, G. Huchon, J.-L. Izquierdo, P. Jones, T. Schaberg, and P.-P. Sagnier Short-term and Long-term Outcomes of Moxifloxacin Compared to Standard Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis Chest, March 1, 2004; 125(3): 953 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V.M. Pinto-Plata, C. Cote, H. Cabral, J. Taylor, and B.R. Celli The 6-min walk distance: change over time and value as a predictor of survival in severe COPD Eur. Respir. J., January 1, 2004; 23(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Chrysofakis, N. Tzanakis, D. Kyriakoy, M. Tsoumakidou, I. Tsiligianni, M. Klimathianaki, and N. M. Siafakas Perforin Expression and Cytotoxic Activity of Sputum CD8+ Lymphocytes in Patients With COPD Chest, January 1, 2004; 125(1): 71 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zaporozhan, S. Ley, K. K. Gast, J. Schmiedeskamp, A. Biedermann, B. Eberle, and H.-U. Kauczor Functional Analysis in Single-Lung Transplant Recipients: A Comparative Study of High-Resolution CT, 3He-MRI, and Pulmonary Function Tests Chest, January 1, 2004; 125(1): 173 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Chen, M. Nakai, A. Aoyama, N. Isowa, and K. Chihara Diaphragmatic elevation of a patient with chronic obstructive pulmonary disease after left upper lobectomy Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 688 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Leidy, S. I. Rennard, J. Schmier, M. K. C. Jones, and M. Goldman The Breathlessness, Cough, and Sputum Scale: The Development of Empirically Based Guidelines for Interpretation Chest, December 1, 2003; 124(6): 2182 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Michalopoulos, S. Geroulanos, and S. D. Mentzelopoulos Determinants of Candidemia and Candidemia-Related Death in Cardiothoracic ICU Patients Chest, December 1, 2003; 124(6): 2244 - 2255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P A Dawkins, L J Dowson, P J Guest, and R A Stockley Predictors of mortality in {alpha}1-antitrypsin deficiency Thorax, December 1, 2003; 58(12): 1020 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. P. Man, F. A. McAlister, N. R. Anthonisen, and D. D. Sin Contemporary Management of Chronic Obstructive Pulmonary Disease: Clinical Applications JAMA, November 5, 2003; 290(17): 2313 - 2316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E{-}J.D. Oudijk, J{-}W.J. Lammers, and L. Koenderman Systemic inflammation in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 5s - 13s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.C. Creutzberg and R. Casaburi Endocrinological disturbances in chronic obstructive pulmonary disease Eur. Respir. J., November 2, 2003; 22(46_suppl): 76s - 80s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Gamble, D. C. Grootendorst, C. E. Brightling, S. Troy, Y. Qiu, J. Zhu, D. Parker, D. Matin, S. Majumdar, A. M. Vignola, et al. Antiinflammatory Effects of the Phosphodiesterase-4 Inhibitor Cilomilast (Ariflo) in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 976 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency Am. J. Respir. Crit. Care Med., October 1, 2003; 168(7): 818 - 900. [Full Text] [PDF]
|
|
|
|
|
|
T R Schermer, J E Jacobs, N H Chavannes, J Hartman, H T Folgering, B J Bottema, and C van Weel Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD) Thorax, October 1, 2003; 58(10): 861 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R G. Barr, B. H Rowe, and C. A Camargo Jr Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials BMJ, September 20, 2003; 327(7416): 643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Antonelli-Incalzi, C. Imperiale, V. Bellia, F. Catalano, N. Scichilone, R. Pistelli, F. Rengo, and the SaRA investigators Do GOLD stages of COPD severity really correspond to differences in health status? Eur. Respir. J., September 1, 2003; 22(3): 444 - 449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The pharmacoepidemiology of COPD: Recent advances and methodological discussion Eur. Respir. J., September 1, 2003; 22(43_suppl): 1s - 44s. [Full Text] [PDF]
|
|
|
|
|
|
D Kohler, J Fischer, F Raschke, and B Schonhofer Usefulness of GOLD classification of COPD severity Thorax, September 1, 2003; 58(9): 825 - 825. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A Dougherty, B. L Didur, and L. S Aboussouan Long-Acting Inhaled {beta}2-Agonists for Stable COPD Ann. Pharmacother., September 1, 2003; 37(9): 1247 - 1255. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.R. Celli, R.J. Halbert, S. Isonaka, and B. Schau Population impact of different definitions of airway obstruction Eur. Respir. J., August 1, 2003; 22(2): 268 - 273. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||